CCND1 amplification and protein overexpression in oral squamous cell carcinoma of young patients

Head and Neck

Volumn 33, Issue 10, 2011, Pages 1413-1419

  Kaminagakura, Estela ^a   Werneck Da Cunha, Isabela ^a   Soares, Fernando Augusto ^a   Nishimoto, Inês Nobuko ^a   Kowalski, Luiz Paulo ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

fluorescence in situ hybridization (FISH); oral cancer; oral squamous cell carcinoma; tissue microarray; young patient

Indexed keywords

CCND1 PROTEIN; CYCLIN D1; PEPTIDES AND PROTEINS; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; ORAL SQUAMOUS CELL CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CYCLIN D1; DISEASE-FREE SURVIVAL; FEMALE; GENE AMPLIFICATION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 80052962062     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21618     Document Type: Article

References (32)

1. Barnes L, Eveson JW, Reichart P, Sidransky D,. World Health Organization Classification of tumors. Pathology and Genetics. Head and Neck. Lyon; IARC press, 2005.
2. Myers JN, Elkins T, Roberts D, Byers RM,. Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes. Otolaryngol Head Neck Surg 2000; 122: 44-51.
3. Pitman KT, Johnson JT, Wagner RL, Myers EN,. Cancer of the tongue in patients less than forty. Head Neck 2000; 22: 297-302.
4. Llewellyn CD, Johnson NW, Warnakulasuriya KA,. Risk factors for squamous cell carcinoma of the oral cavity in young people-a comprehensive literature review. Oral Oncol 2001; 37: 401-418.
5. Llewellyn CD, Linklater K, Bell J, Johnson NW, Warnakulasuriya S,. An analysis of risk factors for oral cancer in young people: a case-control study. Oral Oncol 2004; 40: 304-313.
6. Scully C,. Oral cancer; the evidence for sexual transmission. Br Dent J 2005; 199: 203-207.
7. Scully C, Field JK, Tanzawa H,. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol 2000; 36: 256-263.
8. Lukas J, Aagaard L, Strauss M, Bartek J,. Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control. Cancer Res 1995; 55: 4818-4823.
9. Bova RJ, Quinn DI, Nankervis JS, et al. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue. Clin Cancer Res 1999; 5: 2810-2819.
10. Carlos de Vicente J, Herrero-Zapatero A, Fresno MF, Lõpez-Arranz JS,. Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance. Oral Oncol 2002; 38: 301-308.
11. Mineta H, Miura K, Takebayashi S, et al. Cyclin D1 overexpression correlates with poor prognosis in patients with tongue squamous cell carcinoma. Oral Oncol 2000; 36: 194-198.
12. Wang L, Liu T, Nishioka M, Aguirre RL, Win SS, Okada N,. Activation of ERK1/2 and cyclin D1 expression in oral tongue squamous cell carcinomas: relationship between clinicopathological appearances and cell proliferation. Oral Oncol 2006; 42: 625-631.
13. Fortin A, Guerry M, Guerry R, et al. Chromosome 11q13 gene amplifications in oral and oropharyngeal carcinomas: no correlation with subclinical lymph node invasion and disease recurrence. Clin Cancer Res 1997; 3: 1609-1614.
14. Smith BD, Smith GL, Carter D, et al. Molecular marker expression in oral and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2001; 127: 780-785.
15. Freier K, Joos S, Flechtenmacher C, et al. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma. Cancer Res 2003; 63: 1179-1182.
16. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM,. AJCC Cancer Staging Handbook. Springer Verlag; 2002.
17. Fujii M, Ishiguro R, Yamashita T, Tashiro M,. Cyclin D1 amplification correlates with early recurrence of squamous cell carcinoma of the tongue. Cancer Lett 2001; 172: 187-192.
18. Akervall JA, Michalides RJ, Mineta H, et al. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer 1997; 79: 380-389.
19. Goto H, Kawano K, Kobayashi I, Sakai H, Yanagisawa S,. Expression of cyclin D1 and GSK-3beta and their predictive value of prognosis in squamous cell carcinomas of the tongue. Oral Oncol 2002; 38: 549-556.
20. Miyamoto R, Uzawa N, Nagaoka S, Hirata Y, Amagasa T,. Prognostic significance of cyclin D1 amplification and overexpression in oral squamous cell carcinomas. Oral Oncol 2003; 39: 610-618.
21. Migaldi M, Rossi G, Maiorana A, et al. Superficial papillary urothelial carcinomas in young and elderly patients: a comparative study. BJU Int 2004; 94: 311-316.
22. Mishra R, Das BR,. Cyclin D1 expression and its possible regulation in chewing tobacco mediated oral squamous cell carcinoma progression. Arch Oral Biol 2009; 54: 917-923.
23. Wu M, Putti TC, Bhuiya TA,. Comparative study in the expression of p53, EGFR, TGF-alpha, and cyclin D1 in verrucous carcinoma, verrucous hyperplasia, and squamous cell carcinoma of head and neck region. Appl Immunohistochem Mol Morphol 2002; 10: 351-356.
24. Castle JT, Cardinali M, Kratochvil FJ, et al. P53 and cyclin D1 staining patterns of malignant and premalignant oral lesions in age-dependent populations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88: 326-332.
25. Kaminagakura E, Vartanian JG, da Silva SD, Dos Santos CR, Kowalski LP,. Case control study on prognostic factors in oral squamous cell carcinoma in young patients. Head Neck, 2010 Feb 19 [Epub ahead of print.
26. Angadi PV, Krishnapillai R,. Cyclin D1 expression in oral squamous cell carcinoma and verrucous carcinoma: correlation with histological differentiation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103: e30-35.
27. Nadal A, Jares P, Pinyol M, et al. Association of CDK4 and CCND1 mRNA overexpression in laryngeal squamous cell carcinomas occurs without CDK4 amplification. Virchows Arch 2007; 450: 161-167.
28. Sato-Kuwabara Y, Neves JI, Fregnani JH, Sallum RA, Soares FA,. Evaluation of gene amplification and protein expression of HER-2/neu in esophageal squamous cell carcinoma using Fluorescence in situ Hybridization (FISH) and immunohistochemistry. BMC Cancer 2009; 9: 6.
29. Kyomoto R, Kumazawa H, Toda Y, et al. Cyclin-D1-gene amplification is a more potent prognostic factor than its protein over-expression in human head-and-neck squamous-cell carcinoma. Int J Cancer 1997; 74: 576-581.
30. Motokura T, Arnold A,. Cyclins and oncogenesis. Biochim Biophys Acta 1993; 1155: 63-78.
31. Huang M, Spitz MR, Gu J, et al. Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions. Carcinogenesis 2006; 27: 2034-2037.
32. Guo Y, Stacey DW, Hitomi M,. Post-transcriptional regulation of cyclin D1 expression during G2 phase. Oncogene 2002; 21: 7545-7556.